+
Site Tour

EuroPCR 2023: Pivotal momentum for tricuspid valve intervention

Fabien Praz chairs this panel discussion on the pivotal momentum for tricuspid valve intervention. He is joined by Christian Besler, Phillipp Lurz, Paul Sorajja and Nina Wunderlich.

Related Videos

EuroPCR 2023: Vascular access

EuroPCR 2023: Defining the future

EuroPCR 2023: COAPT 5-year follow-up

EuroPCR 2023: Mitral regurgitation

Trending Controversies | AV Valves

AV VALVES 2023: Replace, Repair in TR

AV VALVES 2023: Fast Forward 20 Years

Abbott TMTI at PCRLV - recorded cases and more

AV VALVES 2023:Decision Making in HF – Mitral

TriClip™: Device features

AV VALVES 2023: TR – Big Gaps

AV VALVES 2023: Live Case – TEER

TRENDING TOPICS

TAVI Webinar 1- Key learnings for advanced TAVI

TAVI Webinar 1- when the present unlocks the future:key learnings for advances TAVI

Treating Large annuli with 35mm Navitor Vision

Achieving optimal outcomes for treatment of large annuli with 35 mm Navitor Vision Valve

PCR Webinar on secondary mitral regurgitation

New evidence reshaping the management of secondary mitral regurgitation

CONNEXT


HUB
RELATED RESOURCES

2-year outcomes from the TRILUMINATE Pivotal trial

ESC 2021: HF & VHD Guidelines

bRIGHT study

CONNEXT


LIVE
RELATED EVENTS

Case Parade | Tricuspid focus

EACVI Summit 2023: Congress symposium

AV VALVES 2023: Trending Topics – QoL

EuroPCR 2023: Tricuspid valve

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline